You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mobocertinib

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mobocertinib in Adults With Lung Cancer in China (MEANING)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • No Intervention
  • Shanghai, China
    Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai J
May 9, 2023

NSCLC Trial (Mobocertinib 160 mg)

Approved for marketing
  • Carcinoma, Non-Small-Cell Lung
  • Mobocertinib 160 mg
  • (no location specified)
Sep 28, 2022

Renal Impairment, Healthy Volunteers Trial in Hialeah, Orlando (Mobocertinib)

Completed
  • Renal Impairment
  • Healthy Volunteers
  • Mobocertinib
  • Hialeah, Florida
  • +1 more
May 11, 2022

Hepatic Impairment, Healthy Volunteers Trial in Hialeah, Orlando (Mobocertinib)

Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • Mobocertinib
  • Hialeah, Florida
  • +1 more
Apr 8, 2022

Healthy Volunteers Trial in Lincoln (Mobocertinib)

Completed
Has Results
  • Healthy Volunteers
  • Mobocertinib
  • Lincoln, Nebraska
    Celerion
Jul 9, 2021

Healthy Volunteers Trial in Lincoln (TAK-788)

Completed
Has Results
  • Healthy Volunteers
  • Lincoln, Nebraska
    Celerion
Aug 10, 2021

NSCLC (NSCLC) Trial (TAK-788, Antidiarrheal prophylaxis)

Withdrawn
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Dec 15, 2020

Healthy Volunteers Trial in Tempe (TAK-788, Itraconazole, Rifampin)

Completed
Has Results
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion
Aug 11, 2020

A Chart Review Study of Adults With Advanced NSCLC

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Aug 1, 2022

    NSCLC Trial in Worldwide (TAK-788)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Birmingham, Alabama
    • +56 more
    Jan 23, 2023